ESMO Congress 2012

Oncology Meeting Resources

28 Sep - 02 Oct, Vienna, Austria

ESMO 2012 Congress

Please find below the links to all ESMO 2012 presentations that have an abstract, poster, slide set or webcast. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Search Meeting Resources by Keyword

 

 

Useful links

Presenter Presentation title Session title
David Cunningham Welcome and introduction Industry Satellite: Sanofi: Choosing an optimal fit: Exploring treatments for the patient with metastatic colorectal cancer
Dirk Arnold Exploring the latest advances for metastatic CRC Industry Satellite: Sanofi: Choosing an optimal fit: Exploring treatments for the patient with metastatic colorectal cancer
David Ferry What to expect: Managing adverse effects of treatments for metastatic CRC Industry Satellite: Sanofi: Choosing an optimal fit: Exploring treatments for the patient with metastatic colorectal cancer
Marc Peeters Clinical cases and panel discussion Industry Satellite: Sanofi: Choosing an optimal fit: Exploring treatments for the patient with metastatic colorectal cancer
David Cunningham Optimizing evidence-based decisions in metastatic CRC Industry Satellite: Sanofi: Choosing an optimal fit: Exploring treatments for the patient with metastatic colorectal cancer
Marc Peeters Clinical cases and panel discussion Industry Satellite: Sanofi: Choosing an optimal fit: Exploring treatments for the patient with metastatic colorectal cancer
Robert Pirker Welcome and introductions from the program chair Industry Satellite: Eli Lilly: Orchestrating progress in patients with advanced NSCLC: A symphony of views
Luis Costa Accelerating drug development from bench to bedside YO Masterclass: Clinical trial protocol development
Heinz Zwierzina Development of biomarkers: Promises and pitfalls YO Masterclass: Clinical trial protocol development
Sarah Brown Phase II clinical trial design and an example of a Flims Workshop protocol YO Masterclass: Clinical trial protocol development
José Baselga Personalised medicine in a leading US cancer center: Today's best practice Industry Satellite: Caris Life Sciences: Evidence based molecular profiling: Putting the theory of personalised medicine into practice
Eric Raymond Welcome and introduction Industry Satellite: Pfizer: Targeted therapies in progressive pancreatic NET: Moving from evidence to experience
Axel Grothey Welcome and session preview Industry Satellite: Bayer: Translating advances in molecular oncology to the clinic for the treatment of mCRC and GIST
Heinz-Josef Lenz Genomic landscape of mCRC and GIST Industry Satellite: Bayer: Translating advances in molecular oncology to the clinic for the treatment of mCRC and GIST
Axel Grothey Targeted agents in the treatment of mCRC Industry Satellite: Bayer: Translating advances in molecular oncology to the clinic for the treatment of mCRC and GIST